Sales for this month
July 2026In July 2026, 1 new company was added to the number of companies from which receivables are purchased, bringing the total to 101 at the end of July. Although operating loans were collected, the investment asset balance increased by ¥4 million from the end of the previous month, to ¥9,605 million, owing to an increase in new receivables purchase transactions.
Collections on operating loans, Increase from new receivables purchase transactions, Addition of 1 new company to the number of companies from which receivables are purchased
A preliminary report on the investment asset balance as of the end of August 2026 is scheduled for 15 September 2026 (Tuesday).
Scope of aggregation: Consolidated
| Item | Details |
|---|---|
| Month Covered | July 2026 |
| Scope of aggregation | Consolidated |
| Sales by category | Purchased Receivables ¥8,840 million, Lease receivables and lease investment assets ¥66 million, Operating loans ¥472 million, Real Estate ¥226 million, Total investment asset balance ¥9,605 million |
| Key KPIs | Number of companies selling medical and long-term care reimbursement receivables 101 companies, Total investment asset balance ¥9,605 million |
| Monthly Commentary | In July 2026, 1 new company was added to the number of companies from which receivables are purchased, bringing the total to 101 at the end of July. Although operating loans were collected, the investment asset balance increased by ¥4 million from the end of the previous month, to ¥9,605 million, owing to an increase in new receivables purchase transactions. |
| Factors Affecting the Change | Collections on operating loans, Increase from new receivables purchase transactions, Addition of 1 new company to the number of companies from which receivables are purchased |
| Next Scheduled Disclosure | A preliminary report on the investment asset balance as of the end of August 2026 is scheduled for 15 September 2026 (Tuesday). |
Items this document does not state (15)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The increase from new receivables purchase transactions exceeded collections of operating loans. The number of companies from which receivables are purchased increased because 1 new company was added.